Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan; Department of Omics Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Biochem Biophys Res Commun. 2020 Nov 19;532(4):620-625. doi: 10.1016/j.bbrc.2020.08.102. Epub 2020 Sep 6.
Adrenic acid (ADA), which is an endogenously synthesized polyunsaturated free fatty acid, was significantly increased in nonalcoholic fatty liver disease (NAFLD) patients and NAFLD-model mice compared with the corresponding controls in our previous study. To elucidate the involvement of ADA in NAFLD and nonalcoholic steatohepatitis (NASH), we examined ADA-induced lipotoxicity in human hepatocarcinoma HepG2 cells. The ROS production in HepG2 cells was increased by exposure to ADA. It was also shown that the treatment with ADA decreased cell viability in a dose-dependent manner. The N-Acetyl-L-Cysteine pretreatment counteracted this ADA-induced ROS production and cell death. Furthermore, ADA modulated the expressions of SOD2, HO-1 and Gpx1 as antioxidant enzymes. These findings suggest that ADA could induce oxidative stress accompanied by cell death, providing new insights into lipotoxicity that is involved in the pathogenesis of NAFLD and NASH.
在我们之前的研究中,与相应的对照组相比,非酒精性脂肪性肝病(NAFLD)患者和 NAFLD 模型小鼠的内源性合成多不饱和游离脂肪酸烯酸(ADA)显著增加。为了阐明 ADA 在非酒精性脂肪性肝病和非酒精性脂肪性肝炎(NASH)中的作用,我们在人肝癌 HepG2 细胞中研究了 ADA 诱导的脂毒性。ADA 暴露可增加 HepG2 细胞中的 ROS 产生。结果表明,ADA 以剂量依赖性方式降低细胞活力。N-乙酰-L-半胱氨酸预处理可拮抗 ADA 诱导的 ROS 产生和细胞死亡。此外,ADA 调节抗氧化酶 SOD2、HO-1 和 Gpx1 的表达。这些发现表明,ADA 可诱导伴有细胞死亡的氧化应激,为涉及 NAFLD 和 NASH 发病机制的脂毒性提供了新的见解。